High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 3, 2024 Category: Allergy & Immunology Authors: Pan LiuXiaohan YangHongyu ZhaoLihua LiangMinchai ChenAihua YinMedical Genetic Center, Guangdong Women and Children Hospital, Guangzhou, China Source Type: research

Understanding healthcare providers ’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 3, 2024 Category: Allergy & Immunology Authors: Salini MohantyJui-Hua TsaiNing NingAna MartinezRishi P. VermaMarieke HeisenJessica WeaverKristen A. FeemsterBianca ChunThomas W. WeissJordana K Schmiera Merck Research Laboratories, Merck & Co. Inc, Rahway, NJ, USAb Evidence & Access, OPEN Health, Bethe Source Type: research

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 2, 2024 Category: Allergy & Immunology Authors: Peter KardosJaime Correia de SousaUlrich HeiningerAndreas KonstantopoulosC. Raina MacIntyreDonald MiddletonTerry NolanAlberto PapiAdrian RendonAlbert RizzoKim SampsonAlessandro SetteElizabeth SobczykTina TanCatherine Weil-OlivierBirgit WeinbergerTom Wilki Source Type: research

Unlocking cancer vaccine potential: What are the key factors?
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 2, 2024 Category: Allergy & Immunology Authors: Michael GrantLian Ni LeeSenthil ChinnakannanOrion TongJonathan KwokNicole CianciLuke TillmanAbhishek SahaVinnycius Pereira AlmeidaCarol Leunga Infinitopes Ltd, Oxford, UKb Oxford Health NHS Foundation Trust, Oxford, UKc University of Oxford, Oxford, UK Source Type: research

Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 2, 2024 Category: Allergy & Immunology Authors: Pierre-Andr é JarrotAdrien MirouseSébastien OttavianiSimon CadiouJean-Hugues SalmonEric LiozonSimon ParreauMartin MichaudBenjamin TerrierPierre-Edouard GavandLudovic TrefondVirginie LavoiepierreJeremy KeraenDaniel RekassaBastien BouldoiresThierry Weitte Source Type: research

Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 2, 2024 Category: Allergy & Immunology Authors: Fanli QuGuanwen WangPing WenXiaoyu LiuXiaohua Zenga Department of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, Chinab Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospita Source Type: research

Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 1, 2024 Category: Allergy & Immunology Authors: Victor Fernandez-AlonsoRuth Gil-PrietoMaria Amado-Anton-PachecoValent ín Hernández-BarreraÁngel Gil-De-Miguela Department of Medical Specialties and Public Health, University Rey Juan Carlos, Alcorcón, Madrid, Spainb Instituto de Investigación Sanita Source Type: research

Positioning implementation science in national immunization programmes to improve coverage equity and advance progress toward Immunization Agenda 2030: An urgent global health imperative
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 1, 2024 Category: Allergy & Immunology Authors: Abdu A. AdamuDuduzile NdwandweRabiu I. JaloCharles S. Wiysongea Cochrane South Africa, South African Medical Research Council, Cape Town, South Africab Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Source Type: research

Effectiveness of Enterovirus 71 inactivated vaccines against hand, foot, and mouth disease: A test-negative case-control study
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 28, 2024 Category: Allergy & Immunology Authors: Yutong ZhangJinzhao CuiFengfeng LiuYang SongQuanyi WangYanzhe LiuYanping ZhangZhongjie LiZhaorui Changa Division of Infectious Disease, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Con Source Type: research

Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 28, 2024 Category: Allergy & Immunology Authors: Ankur TiwariKarl AlcoverElizabeth CarpenterKatryna ThomasJulia KrumAlexander NissenSpencer Van DecarTodd SmolinskyFranklin ValderaTimothy VreelandMarkus LacherGiuseppe Del PrioreWilliam WilliamsAlexander StojadinovicGeorge PeoplesGuy Cliftona Department o Source Type: research

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27 –45 years
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 28, 2024 Category: Allergy & Immunology Authors: Natalie L. RinconKelsey Rae McDowellDarien WeatherspoonTiarney D. RitchwoodDaniel J. RockeEric Adjei BoakyeNosayaba Osazuwa-Petersa Trinity College of Arts & Sciences, Duke University, Durham, NC, USAb REACH Equity Summer Undergraduate Research Program ( Source Type: research

Reply to “Knowledge-map analysis and bladder cancer immunotherapy: Comment”
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 27, 2024 Category: Allergy & Immunology Authors: Zongwei LvJunhui HouYuan WangXia WangYibing WangKefeng Wanga Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Chinab Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China Source Type: research

HV & I Reviewer Highlight
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 27, 2024 Category: Allergy & Immunology Authors: Ronald EllisAdam Weissa Editor-in-Chief, Jerusalem, Israelb Acquisitions Editor, Taylor & Francis Group Source Type: research

COVID-19 vaccination perspectives among patients with Long COVID: A qualitative study
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 27, 2024 Category: Allergy & Immunology Authors: Sarah R. MacEwanSaurabh RahurkarWilli L. TarverAlice A. GaughanLaura J. RushAndrew SchamessAnn Scheck McAlearneya Division of General Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USAb Center for the Advancement of Team Source Type: research

Enhancing routine immunization efforts for older adults and frail individuals: Good practices during the SARS-CoV-2 pandemic in Italy
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 27, 2024 Category: Allergy & Immunology Authors: Andrea PosciaGiulia PaolorossiAgnese CollamatiClaudio CostantinoDaniel FiacchiniClaudio AngeliniRoberto BernabeiDaniela CiminiGiancarlo IcardiAndrea SidduAndrea SilenziAntonietta SpadeaDavide Liborio Vetranoa Public Health Department, AST Ancona, Ancona, Source Type: research